1Ohno R, Asou N, Ohnishi K.Treatment of acute promyelocytic[J].Leukemia,2003,17(8):1454-1463.
2Lengfelder E, Gnad U, Buchner T, et al. Treatment of relapsed acute promyelocytic leukemia[J].Onkologie,2003,26(4):373-379.
3Lazo G, Katarjian H,Estey E,et al. Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia[J].Cancer,2003,97(9):2218-2224.
4Jing YK,Wang L,Xiu LJ,et al. Combined effect of all-trans retinoic acid and arsenic trioxiode in acute promyelocytic leukemia cell in vitro and vivo[J].Blood,2001,97(1):264-269.
5Roffoux E,Rousselot P,Poupon J,et al. Combined treatment with arsenic trioxide and all-trans retinoic acid in patients with relapsed acute promyelocytic leukemia[J].J Clin Oncol,2003,21(12):2326-2334.
3Tallman MS,Andersen JW,Schiffer CA,et al.Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome[J].Blood,2001,95:90-95.
4Melnick A,Licht JD.Deconstructing a disease:RARalpha,its fusion partners,and their roles in the pathogenesis of acute promyelocytic leukemia[J].Blood,1999,93:3167-3215.
